Patriot Financial Group Insurance Agency’s Intellia Therapeutics NTLA Stock Holding History

Patriot Financial Group Insurance Agency’s Portfolio NTLA Stock Details NTLA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-157	Closed	-$8K	–	1413
2022 Q2	$8K	Sell	157 -14	-8%	-$711	﹤0.01%	1339
2022 Q1	$12K	Buy	171 +4	+2%	+$339	﹤0.01%	1290
2021 Q4	$20K	Buy	167 +12	+8%	+$1.5K	﹤0.01%	1223
2021 Q3	$21K	Buy	155 +12	+8%	+$1.82K	﹤0.01%	1191
2021 Q2	$23K	Buy	143 +43	+43%	+$3.35K	﹤0.01%	1121
2021 Q1	$8K	Hold	100	–	–	﹤0.01%	1432
2020 Q4	$5K	Hold	100	–	–	﹤0.01%	1437
2020 Q3	$2K	Hold	100	–	–	﹤0.01%	1469
2020 Q2	$2K	Sell	100 -16,008	-99%	-$272K	﹤0.01%	1409
2020 Q1	$197K	Buy	16,108 +4,893	+44%	+$65.9K	0.09%	214
2019 Q4	$165K	Buy	+11,215	New	+$156K	0.06%	249
2019 Q3	–	Sell	-1,500	Closed	-$24K	–	1412
2019 Q2	$24K	Buy	+1,500	New	+$23.6K	0.01%	588
2019 Q1	–	Sell	-5,495	Closed	-$75K	–	1285
2018 Q4	$75K	Buy	5,495 +1,450	+36%	+$27K	0.05%	262
2018 Q3	$116K	Buy	+4,045	New	+$118K	0.07%	188

Other funds holding NTLA

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Patriot Financial Group Insurance Agency's NTLA Position: Q3 2022 in Review

Patriot Financial Group Insurance Agency sold out of Intellia Therapeutics (NTLA) in Q3 2022, closing a stake of 157 shares — an estimated $8K sold.

Patriot Financial Group Insurance Agency first reported a position in NTLA in Q3 2018 and held it in 14 quarters. The position peaked at $197K in Q1 2020. 320 funds tracked by Wall St. Rank hold NTLA as of Q3 2022.

Patriot Financial Group Insurance Agency reported no remaining Intellia Therapeutics position as of Q3 2022 after selling out during the quarter.
Patriot Financial Group Insurance Agency sold 157 Intellia Therapeutics shares in Q3 2022, an estimated $8K.
Patriot Financial Group Insurance Agency first reported a position in Intellia Therapeutics in Q3 2018 and held it in 14 quarters.
Patriot Financial Group Insurance Agency's Intellia Therapeutics position peaked at $197K in Q1 2020.
320 funds tracked by Wall St. Rank held Intellia Therapeutics as of Q3 2022.

Based on Patriot Financial Group Insurance Agency's 13F filing for Q3 2022, filed 1 Nov 2022.